Plain-English translation of NCT07842146 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Urolithin A (Mitopure®), a natural substance produced by your gut after eating pomegranates, nuts, and berries, to see if it can help people with Alzheimer's disease or early memory problems. Researchers believe this medication may help brain cells work better by boosting energy production in the mitochondria—the 'power plants' of your cells. The study will look at whether this treatment can slow cognitive decline and reduce harmful proteins that build up in the brains of people with Alzheimer's.
Alzheimer's disease damages the brain's ability to clear out harmful proteins, and one reason this happens may be that brain cells don't have enough energy to do the cleanup work. This medication is being tested because early research in animals and lab studies suggests it could give brain cells the energy boost they need to protect against memory loss.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either the natural supplement or a placebo (inactive pill) once daily. During the study, you'll have regular visits where researchers will test your memory and thinking, check biomarkers in your blood or spinal fluid to see how your brain is responding, and monitor your overall health. Your study partner will help support you throughout the trial, and the entire study involves a total of 60 participants being recruited across the research site.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Czechia